Circulating Methylated DNA
- 1 June 2004
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1022 (1) , 33-39
- https://doi.org/10.1196/annals.1318.006
Abstract
Early detection of cancer would facilitate better management of patients, because survival is greatly affected by stage of presentation. Circulating nucleic acids represent a biomarker that might be used in the early detection of cancer. In addition, such biomarkers could potentially be used to follow the progression of patients with cancer. DNA methylation of the promoter region CpG islands of genes represents one such nucleic acid-based marker, and possesses some advantages over other approaches. These include the stability of DNA as a molecule, the ability to detect such changes using simple polymerase chain reaction-based approaches, and the potential for methylated DNA to be preferentially present in nucleosomes in plasma or serum. These factors are presented and their impact on the detection of methylated DNA circulating in the bloodstream is demonstrated.Keywords
This publication has 23 references indexed in Scilit:
- Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancerUrology, 2002
- Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancerOncogene, 2001
- Nucleosomes in serum of patients with benign and malignant diseasesInternational Journal of Cancer, 2001
- Methylation-specific PCR (MSP) for detection of tumour DNA in the blood plasma and serum of patients with prostate cancerProstate Cancer and Prostatic Diseases, 2000
- Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung CarcinomasJNCI Journal of the National Cancer Institute, 2000
- Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3Nature Genetics, 2000
- Selective variegated methylation of thep15 CpG island in acute myeloid leukemiaInternational Journal of Cancer, 1998
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.Proceedings of the National Academy of Sciences, 1992